Larvol Delta - Abpro-Announces-Initiation-of-Phase-23-Registrational-Studies-of-its-Neutralizing-Antibody-Therapeutic-ABP-300-for-the-Treatment-of-COVID19

ABP-300 - Abpro Therap, BIO invest

http://www.globenewswire.com/news-release/2020/12/16/2146197/0/en/Abpro-Announces-Initiation-of-Phase-2-3-Registrational-Studies-of-its-Neutralizing-Antibody-Therapeutic-ABP-300-for-the-Treatment-of-COVID-19.html

Dec 16, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next